Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717663 · ClinicalTrials.gov registry record · NA
WalkIT Arizona: Walking Interventions Through Texting
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 512
- Enrollment target
NCT02717663: Completed NA study, sponsored by Arizona State University.
NCT02717663 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 512 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02717663, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
Study Summary
The purpose of this study is to develop adaptive (AI) and micro-incentive (MI) interventions and test them against static (SI) and delayed-incentive (DI) interventions in a 4-arm randomized factorial trial to increase MVPA adoption and maintenance among inactive adults. Using neighborhood walkability and socioeconomic status, participants will be recruited from four neighborhood types: "high walkable/high SES," "high walkable/low SES," "low walkable/high SES," and "low walkable/low SES." We will evaluate synergistic or antagonistic effects of interventions and neighborhood factors on MVPA adoption by 12 months and maintenance by 24 months.
Interventions
- BEHAVIORAL Adaptive Goals
- BEHAVIORAL Static Goals
- BEHAVIORAL Delayed (non-contingent) Incentives
- BEHAVIORAL Immediate Micro-Incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2016-05 |
| Est. Completion | 2020-08 |
| Phase | NA |
What the finished NCT02717663 record still lists
NCT02717663 is an interventional study that assigns participants to a tested intervention. The registered 512 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 4 interventions - of which Adaptive Goals is the first listed.
NCT02717663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02717663 about?
NCT02717663 is a clinical study titled "WalkIT Arizona: Walking Interventions Through Texting". The purpose of this study is to develop adaptive (AI) and micro-incentive (MI) interventions and test them against static (SI) and delayed-incentive (DI) interventions in a 4-arm randomized factorial trial to increase MVPA adoption and maintenance among inactive adults. Using neighborhood walkabilit...
What is the current status of trial NCT02717663?
This trial is currently completed. It is a NA study. The enrollment target is 512 participants. The study started on 2016-05. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02717663?
The interventions under investigation include: Adaptive Goals (BEHAVIORAL), Static Goals (BEHAVIORAL), Delayed (non-contingent) Incentives (BEHAVIORAL), Immediate Micro-Incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT02717663?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02717663's enrollment target sits among peer trials
512 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia